AI-POWERED FDSO ANALYSIS

You are an expert financial analyst tasked with identifying ALL dilutive securities from a 10-K filing.

OBJECTIVE:
Analyze the entire 10-K document and identify every security that could dilute common shareholders.
Make your own independent determination about what exists in the document.

SECURITIES TO IDENTIFY:

1. **Stock Options**
   - Look for: Stock option tables, option activity, vested/unvested options
   - Extract: Total outstanding, vested shares, unvested shares, weighted average exercise prices (WAEP)
   - Context: Vesting schedules, expiration dates

2. **Restricted Stock Units (RSUs)**
   - Look for: RSU tables, unvested restricted stock
   - Extract: Outstanding unvested RSUs, expected to vest
   - Note: RSUs have NO exercise price (distinguish from options)

3. **Performance Stock Units (PSUs)**
   - Look for: Performance-based awards, target/maximum payouts
   - Extract: Target payout shares, maximum payout shares
   - Context: Performance conditions

4. **Warrants**
   - Look for: Warrant tables, pre-funded warrants, placement agent warrants
   - Extract: Each warrant tranche separately with shares and exercise prices
   - Note: Pre-funded warrants typically have $0.0001 exercise price

5. **Convertible Debt/Notes**
   - Look for: Convertible note disclosures, conversion prices
   - Extract: Principal amount, conversion price, shares issuable upon conversion

6. **Convertible Preferred Stock**
   - Look for: Preferred stock with conversion rights
   - Extract: Shares outstanding, conversion ratio, shares issuable

7. **SARs (Stock Appreciation Rights)**
   - Look for: SAR disclosures
   - Extract: Outstanding SARs, exercise prices

8. **ESPP (Employee Stock Purchase Plan)**
   - Look for: ESPP plan disclosures, shares reserved
   - Extract: Shares available/reserved for future purchase

9. **Other Dilutive Securities**
   - Earnouts, contingent consideration, rights, any instrument convertible to common stock

CRITICAL VESTING DISTINCTION:
- **VESTED/EXERCISABLE**: Can be exercised NOW - currently dilutive
- **UNVESTED/OUTSTANDING**: Will vest in future - potentially dilutive
- **EXERCISED/VESTED DURING PERIOD**: Historical activity - DO NOT INCLUDE (already in basic shares)

ANALYSIS APPROACH - WHERE TO FIND DILUTIVE SECURITIES:
1. **PRIORITY: Notes to Financial Statements** (typically Note 10-15) - THIS IS THE MOST IMPORTANT SECTION
   - Stock-Based Compensation note (usually Note 12-13)
   - Equity/Shareholders' Equity note
   - Stock option activity tables with vested/unvested breakdowns
   - RSU/PSU activity tables
   - Warrant disclosures

2. **EPS Disclosures** (typically Note 16-18: Earnings Per Share)
   - Diluted EPS calculations
   - Anti-dilutive securities excluded from EPS
   - Schedule of potential common shares

3. **Convertible Debt Notes** (typically Note 9-11: Debt/Long-term Obligations)
   - Convertible notes disclosures
   - Conversion prices and shares issuable

4. **Cover Page** - Basic shares outstanding as of filing date

5. **Equity section of Balance Sheet** - Outstanding preferred stock

CRITICAL: Focus your analysis primarily on the NOTES TO FINANCIAL STATEMENTS section. This is where all detailed dilutive securities data is disclosed with tables showing vested/unvested amounts, exercise prices, and activity.

OUTPUT FORMAT (JSON):
{{
  "ticker": "EXAMPLE",
  "filing_date": "2024-12-31",
  "filing_url": "{filing_url}",
  "analysis_complete": true,

  "basic_shares_outstanding": {{
    "shares": 76542811,
    "as_of_date": "2024-12-31",
    "source": "Cover page - Entity Common Stock, Shares Outstanding",
    "evidence": "Direct quote from document"
  }},

  "stock_options": {{
    "found": true,
    "total_outstanding": 10700000,
    "vested_exercisable": 5000000,
    "vested_waep": 12.50,
    "unvested": 5700000,
    "unvested_waep": 18.75,
    "source": "Note 12 - Stock-Based Compensation, Option Activity Table",
    "evidence": "As of December 31, 2024: Options outstanding 10,700,000; Exercisable 5,000,000",
    "vesting_schedule": "Generally vest over 4 years"
  }},

  "rsus": {{
    "found": true,
    "outstanding_unvested": 3500000,
    "expected_to_vest": 3200000,
    "source": "Note 12 - Restricted Stock Unit Activity",
    "evidence": "Unvested RSUs at December 31, 2024: 3,500,000 shares",
    "vesting_schedule": "Time-based, generally 3-4 years"
  }},

  "psus": {{
    "found": true,
    "target_payout": 500000,
    "maximum_payout": 1000000,
    "source": "Note 12 - Performance-Based Awards",
    "evidence": "Target performance shares: 500,000; Maximum: 1,000,000",
    "performance_period": "2024-2026"
  }},

  "warrants": [
    {{
      "description": "Pre-funded warrants",
      "shares": 1500000,
      "exercise_price": 0.0001,
      "expiration": null,
      "source": "Note 11 - Stockholders' Equity",
      "evidence": "Pre-funded warrants outstanding: 1,500,000 at exercise price $0.0001"
    }},
    {{
      "description": "Series A warrants from 2023 financing",
      "shares": 700000,
      "exercise_price": 25.00,
      "expiration": "2028-06-30",
      "source": "Note 11 - Warrant disclosures",
      "evidence": "Series A warrants: 700,000 shares exercisable at $25.00"
    }}
  ],

  "convertible_debt": [
    {{
      "description": "2025 Convertible Senior Notes",
      "principal_amount": 200000000,
      "conversion_price": 50.00,
      "shares_issuable": 4000000,
      "maturity_date": "2025-12-15",
      "source": "Note 9 - Convertible Debt",
      "evidence": "$200M convertible notes at $50/share conversion price"
    }}
  ],

  "sars": {{
    "found": false,
    "source": "Not mentioned in filing"
  }},

  "espp": {{
    "found": true,
    "shares_reserved": 2000000,
    "shares_available": 1200000,
    "source": "Note 12 - Employee Stock Purchase Plan",
    "evidence": "Shares available for future issuance under ESPP: 1,200,000"
  }},

  "convertible_preferred": [],

  "other_dilutive_securities": [],

  "anti_dilutive_excluded": [
    {{
      "type": "Stock options",
      "shares": 2000000,
      "reason": "Exercise price exceeds market price",
      "source": "Note 16 - Earnings Per Share, anti-dilutive table"
    }}
  ],

  "summary": {{
    "total_dilutive_securities_vested": 8700000,
    "total_dilutive_securities_unvested": 10200000,
    "total_potential_dilution": 18900000,
    "confidence": "HIGH",
    "notes": "Comprehensive analysis completed. All major dilutive security categories reviewed."
  }}
}}

IMPORTANT RULES:
1. All share counts must be integers, all prices must be decimals
2. Use null for fields not found, [] for empty arrays
3. Include source evidence for every found security (direct quotes)
4. Distinguish between vested (current) and unvested (future) dilution
5. Be aggressive - if unsure whether something is dilutive, INCLUDE IT
6. For nominal exercise prices (de minimis), use 0.0001
7. Look at ENDING BALANCES from activity tables, not activity during period

10-K DOCUMENT TO ANALYZE:
---
Company Ticker: {ticker}
Filing Date: {filing_date}
10-K URL: {filing_url}

FULL 10-K CONTENT:
{filing_content}
---

Analyze the 10-K content above and identify ALL dilutive securities (vested and unvested).
Make your own independent determination about what securities exist in the document.

Return ONLY the JSON, no other text or markdown formatting.